Secondary outcome measures
| Outcome | Standard | Intervention | p Value |
|---|---|---|---|
| MAI, median (IQR) | |||
| Summated MAI pre-admission | 3 (1 to 6.8) | 4 (1 to 7.5) | 0.538 |
| Summated MAI admission | 4 (2 to 7) | 2.5 (1 to 5) | 0.013 |
| Summated MAI discharge | 6 (3 to 9) | 2 (0 to 4) | 0.000 |
| Difference preadmission to admission, summated MAI | 0 (−2 to 4) | −0.5 (−3 to 0) | 0.006 |
| Difference preadmission to discharge, summated MAI | 1 (−1 to 6) | −1 (−3.8 to 0) | 0.000 |
| Process measures | χ2, p value, df | ||
| Clinical pharmacist suggestion made per patient, n (%) | 73/121 (60.3%) | 86/112 (76.8%) | 7.3, =0.005, 1 |
| Clinical pharmacist suggestion made per medication, n (%) | 200/1231 (16.2%) | 261/1093 (23.9%) | 21.2, =0.000, 1 |
| Acceptance of clinical pharmacist suggestions n (%) of suggestions | |||
| Accepted during admission | 111 (55.5%) | 240 (92.0%) | 91.9, =0.000, 2 |
| Accepted at discharge | 24 (12.0%) | 16 (6.1%) | |
| Not accepted | 65 (32.5%) | 5 (1.9%) | |
MAI, Medication Appropriateness Index (increase in score represents reduction in quality of prescribing).